Independent Research GmbH set a €88.00 ($103.53) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note issued to investors on Wednesday morning. The firm currently has a neutral rating on the stock.

A number of other brokerages have also recently commented on FME. Nord/LB set a €93.00 ($109.41) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Thursday, May 4th. J P Morgan Chase & Co set a €104.50 ($122.94) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Thursday, May 4th. S&P Global set a €88.00 ($103.53) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research report on Wednesday, May 3rd. Kepler Capital Markets set a €95.00 ($111.76) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Wednesday, May 3rd. Finally, Commerzbank Ag set a €88.00 ($103.53) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research report on Wednesday, May 3rd. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating to the company. The company presently has a consensus rating of Hold and an average target price of €88.07 ($103.61).

Fresenius Medical Care AG & Co. KGaA (ETR FME) opened at 79.159 on Wednesday. The stock has a 50 day moving average price of €84.82 and a 200-day moving average price of €81.06. The company has a market cap of €24.29 billion and a price-to-earnings ratio of 20.412. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €70.82 and a 12-month high of €89.07.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Daily Political and is the property of of Daily Political. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/08/06/fresenius-medical-care-ag-88-00-price-target-at-independent-research-gmbh.html.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.